Essential Courses for DEA Registration Renewal by CE Zoom, ADA-CERP Provider
Course Bundle
by CE Zoom Virtual CE Hub
Self Study
On Demand
Essential Courses for DEA Registration Renewal by CE Zoom, ADA-CERP Provider
by CE Zoom Virtual CE Hub
Essential Courses for DEA Registration Renewal by CE Zoom, ADA-CERP Provider
Self Study
On Demand
by CE Zoom Virtual CE Hub
Register for this Course
Are you a CE Zoom Member?
CE Zoom Virtual CE Hub has partnered with CE Zoom for the distribution of CE Certificates.
Please register for each course being offered, for which you wish to receive a CE Certificate of Attendance.
Registration is FREE.
Login using your CE Zoom account.
Not a CE Zoom member?
Overview
All courses are now available!
To find these courses after registering, log into your CE Zoom Dashboard.
Select Scheduled Self-Study Courses > Take Course
The United States Congress passed a new law requiring prescribers of controlled substances to complete (8.00) eight hours of one-time training on safely prescribing controlled substances to renew a U.S. Drug Enforcement Administration (DEA) Registration on or after June 27th, 2023.
Register now and secure your access to the courses when they are released in mid-June! Each course is 2.00 hours long, totaling 8.00 CE hours. The Registration will allow you to have access to all four courses as a bundle.
Presenter: Arthur H. Jeske, D.M.D., Ph.D.
Dr. Jeske is Professor, Department of General Practice and Dental Public Health and Associate Dean for Strategic Planning & Continuing Dental Education, at the University of Texas School of Dentistry at Houston. He earned his Ph.D. degree (pharmacology) and his D.M.D. degree at the Medical College of Georgia. Dr. Jeske is the Editor of Contemporary Dental Pharmacology: Evidence-Based Considerations (Springer Publishing, Berlin), Editor-in-Chief of Mosby’s Dental Drug Reference, andSection Editor (Pharmacology) of the Journal of Craniomandibular and Sleep Practice. He has served on the American Dental Association’s Council on Scientific Affairs and served as an Evidence Reviewer for the American Dental Association’s Center for Evidence-Based Dentistry. He is a Fellow of the International College of Dentists, the American College of Dentists, the Academy of Dentistry International, and the Pierre Fauchard Academy. Dr. Jeske holds memberships in the ADA, TDA, and GHDS, as well as Omicron Kappa Upsilon and Delta Sigma Delta, and he is the recipient of the Distinguished Alumnus Award from the Medical College of Georgia School of Dentistry. Dr. Jeske has been in the private practice of general dentistry for 40 years.
Prerequisites : None
Conflict of Interest Disclosure: No Conflicts of Interest
Course 1: The Opioid Epidemic and Opioid Alternatives for Pain Control
Description: The Opioid Epidemic now claims over 100,000 lives per year in the United States and there is no indication that the upward trajectory of overdose deaths will abate in the foreseeable future. Health care professionals, including dentists, dental hygienists and dental assistant, should understand the evolving pattern of illicit drug use in the U.S., as well as the types of drugs being diverted and abuse, to provide safe dental treatment to patients who may be affected by Substance Use Disorder (SUD). This program updates dental professionals on the current status of the Opioid Epidemic, its implications for patient management, and reviews non-addictive drugs that can be used in place of opioids for dental pain management.
Course Objectives:
1. Review current CDC data on patterns of illicit drug use and their impact on
dentistry;
2. Using scientific evidence, select drugs that can be used to manage acute dental
pain with efficacy equal or superior to that of opioid analgesics; and
3. Review laws and governmental policies related to the opioid epidemic that
impact the dental profession.
Course Presenter: Arthur H. Jeske, Ph.D., D.M.D.
Dr. Jeske is Professor, Department of General Practice and Dental Public Health and
Associate Dean for Strategic Planning & Continuing Dental Education, University of Texas School of Dentistry at Houston.He earned his Ph.D. degree (pharmacology) and his D.M.D. degree at the Medical College of Georgia.Dr. Jeske is Editor of Contemporary Dental Pharmacology:Evidence-Based Considerations (Springer Publishing, Berlin), Editor-in-Chief of Mosby’s Dental Drug Reference andSection Editor (Pharmacology) of the Journal of Craniomandibular and Sleep Practice.He has served on the American Dental Association’s Council on Scientific Affairs and served as an Evidence Reviewer for the American Dental Association’s Center for Evidence-Based Dentistry.He is a Fellow of the International College of Dentists, the American College of Dentists, the Academy of Dentistry International and the Pierre Fauchard Academy.Dr. Jeske holds memberships in the ADA, TDA and GHDS, as well as Omicron Kappa Upsilon and Delta Sigma Delta, and he is recipient of the Distinguished Alumnus Award from the Medical College of Georgia School of Dentistry.Dr. Jeske has been in the private practice of general dentistry for 40 years.
'
AGD Subject Code: Chemical Dependency/ Prescribing & Disposal of Prescription Drugs - 134
Cancellation Policy:
Processing and service fees are non-refundable for any and all cancellations with no exceptions. Refunds will only be issued if requested 8 days or more prior to the event. No refunds will be given within 7 days of the event unless the event is canceled by CE Zoom, or unforeseen acts of God, in which we will try and reschedule the event prior to issuing a full refund, minus any processing fees.. Please note, if this is a live-streamed event, you must have a good internet connection and refunds will not be issued due to poor connection or courses not counting for CE credit. If your cancellation/refund request falls within the refund guidelines please email support.cezoom.com and we will be happy to honor your request.
Disclaimer:
The information provided in courses through CE Zoom Partners, LLC (“CE Zoom”) contains content, views, and opinions that may not represent the views of CE Zoom, its associates, and sponsored affiliates. Participants are responsible for verifying the validity, accuracy, and relevance of all content before implementing any techniques, products, or recommendations into their practice. A single continuing education course does not provide enough information to give the participant the necessary expertise on the topic presented.
The content of the courses may not be recorded or copied. The content of the courses is owned by the presenters, CE Zoom, its associates, or sponsored affiliates. Participants may not share or make available, in any way, the content of the courses.
Provider Approval: (ADA-CERP) American Dental Association Continuing Education Recognition Program approved providers, Nationally Recognized (AGD-PACE) Academy of General Dentistry Program approval for Continuing Education
DEA Course 2: Safe and Effective Prescription of Opioids for Dental Pain and Prevention of Abuse and Diversion
Description: Dentists and physicians are prescribing fewer opioids than in the past, due largely to factors emanating from the Opioid Epidemic, including greater regulatory/governmental oversight of opioid prescribing. However, for select cases in which non-opioids cannot be used to control acute postoperative pain,
dental professionals can safely use opioids for dental pain management using scientific evidence to achieve maximum efficacy, while limiting doses prescribed.
This program reviews the pharmacology of opioid analgesics, and the specific agents supported by evidence from systematic reviews. Included in this presentation are recognition of patient characteristics to prevent abuse and diversion, as well as ethical considerations and standards of care that must be considered when prescribing opioids.
Course Objectives:
Use scientific evidence to select opioid analgesics for the management of acute postoperative pain in a manner that minimizes opioid exposure and maximizes pain control;
Recognize characteristics of patients that can indicate potential abuse and diversion of controlled substances; and
Review laws and governmental policies related to the prescription of opioids and standards of care and ethical considerations related to the use of controlled substances in dentistry.
Course Presenter: Arthur H. Jeske, Ph.D., D.M.D.
Dr. Jeske is Professor, Department of General Practice and Dental Public Health and
Associate Dean for Strategic Planning & Continuing Dental Education, University of Texas School of Dentistry at Houston.He earned his Ph.D. degree (pharmacology) and his D.M.D. degree at the Medical College of Georgia.Dr. Jeske is Editor of Contemporary Dental Pharmacology:Evidence-Based Considerations (Springer Publishing, Berlin), Editor-in-Chief of Mosby’s Dental Drug Reference andSection Editor (Pharmacology) of the Journal of Craniomandibular and Sleep Practice.He has served on the American Dental Association’s Council on Scientific Affairs and served as an Evidence Reviewer for the American Dental Association’s Center for Evidence-Based Dentistry.He is a Fellow of the International College of Dentists, the American College of Dentists, the Academy of Dentistry International and the Pierre Fauchard Academy.Dr. Jeske holds memberships in the ADA, TDA and GHDS, as well as Omicron Kappa Upsilon and Delta Sigma Delta, and he is recipient of the Distinguished Alumnus Award from the Medical College of Georgia School of Dentistry.Dr. Jeske has been in the private practice of general dentistry for 40 years.
'
AGD Subject Code: Chemical Dependency/ Prescribing & Disposal of Prescription Drugs - 134
Cancellation Policy:
Processing and service fees are non-refundable for any and all cancellations with no exceptions. Refunds will only be issued if requested 8 days or more prior to the event. No refunds will be given within 7 days of the event unless the event is canceled by CE Zoom, or unforeseen acts of God, in which we will try and reschedule the event prior to issuing a full refund, minus any processing fees.. Please note, if this is a live-streamed event, you must have a good internet connection and refunds will not be issued due to poor connection or courses not counting for CE credit. If your cancellation/refund request falls within the refund guidelines please email support.cezoom.com and we will be happy to honor your request.
Disclaimer:
The information provided in courses through CE Zoom Partners, LLC (“CE Zoom”) contains content, views, and opinions that may not represent the views of CE Zoom, its associates, and sponsored affiliates. Participants are responsible for verifying the validity, accuracy, and relevance of all content before implementing any techniques, products, or recommendations into their practice. A single continuing education course does not provide enough information to give the participant the necessary expertise on the topic presented.
The content of the courses may not be recorded or copied. The content of the courses is owned by the presenters, CE Zoom, its associates, or sponsored affiliates. Participants may not share or make available, in any way, the content of the courses.
Provider Approval: (ADA-CERP) American Dental Association Continuing Education Recognition Program approved providers, Nationally Recognized (AGD-PACE) Academy of General Dentistry Program approval for Continuing Education
DEA Course 3: Identifying Substance Use Disorder in Dental Patients and the Dental Management of Patients with Substance Use Disorders
Description: The Opioid Epidemic now claims over 100,000 lives per year in the United States and there is no indication that the upward trajectory of overdose deaths will abate in the foreseeable future. Health care professionals, including dentists, dental hygienists and dental assistant, should understand the evolving pattern of illicit drug use in the U.S., as well as the types of drugs being diverted and abuse, to provide safe dental treatment to patients who may be affected by
Substance Use Disorder (SUD). This program updates dental professionals on the current status of the Opioid Epidemic, the recognition of SUDs in dental patients, the implications of SUDs for patient management, and reviews non-addictive drugs that can be used in place of opioids for dental pain management. 2 hours C.D.E.
Course Objectives:
Review the scope and current status of the opioid epidemic and related issues;
Understand methods that the dental team can use to identify patients with Substance Use Disorder (SUD);
Review the dental management of patients with specific types of SUD;
Recognize and prevent potential adverse drug-drug interactions when treating patients with SUD;
Review appropriate drug therapies for managing pain and dental infections in patients with SUD;
Utilize effective tools for patient communication about opioids and other controlled substances.
Course Presenter: Arthur H. Jeske, Ph.D., D.M.D.
Dr. Jeske is Professor, Department of General Practice and Dental Public Health and
Associate Dean for Strategic Planning & Continuing Dental Education, University of Texas School of Dentistry at Houston.He earned his Ph.D. degree (pharmacology) and his D.M.D. degree at the Medical College of Georgia.Dr. Jeske is Editor of Contemporary Dental Pharmacology:Evidence-Based Considerations (Springer Publishing, Berlin), Editor-in-Chief of Mosby’s Dental Drug Reference andSection Editor (Pharmacology) of the Journal of Craniomandibular and Sleep Practice.He has served on the American Dental Association’s Council on Scientific Affairs and served as an Evidence Reviewer for the American Dental Association’s Center for Evidence-Based Dentistry.He is a Fellow of the International College of Dentists, the American College of Dentists, the Academy of Dentistry International and the Pierre Fauchard Academy.Dr. Jeske holds memberships in the ADA, TDA and GHDS, as well as Omicron Kappa Upsilon and Delta Sigma Delta, and he is recipient of the Distinguished Alumnus Award from the Medical College of Georgia School of Dentistry.Dr. Jeske has been in the private practice of general dentistry for 40 years.
AGD Subject Code: Chemical Dependency/ Prescribing & Disposal of Prescription Drugs - 134
Cancellation Policy:
Processing and service fees are non-refundable for any and all cancellations with no exceptions. Refunds will only be issued if requested 8 days or more prior to the event. No refunds will be given within 7 days of the event unless the event is canceled by CE Zoom, or unforeseen acts of God, in which we will try and reschedule the event prior to issuing a full refund, minus any processing fees.. Please note, if this is a live-streamed event, you must have a good internet connection and refunds will not be issued due to poor connection or courses not counting for CE credit. If your cancellation/refund request falls within the refund guidelines please email support.cezoom.com and we will be happy to honor your request.
Disclaimer:
The information provided in courses through CE Zoom Partners, LLC (“CE Zoom”) contains content, views, and opinions that may not represent the views of CE Zoom, its associates, and sponsored affiliates. Participants are responsible for verifying the validity, accuracy, and relevance of all content before implementing any techniques, products, or recommendations into their practice. A single continuing education course does not provide enough information to give the participant the necessary expertise on the topic presented.
The content of the courses may not be recorded or copied. The content of the courses is owned by the presenters, CE Zoom, its associates, or sponsored affiliates. Participants may not share or make available, in any way, the content of the courses.
Provider Approval: (ADA-CERP) American Dental Association Continuing Education Recognition Program approved providers, Nationally Recognized (AGD-PACE) Academy of General Dentistry Program approval for Continuing Education
Course 4: Part 1: Management of Emergency Opioid Overdose in the Dental
Office
Part 2: Cannabis and Related Dental Considerations.
Description: The Opioid Epidemic now claims over 100,000 lives per year in the United States and there is now a heightened need for the management of opioid overdoses by healthcare professionals, including dentists, dental hygienists and dental assistants. Along with opioids, the dental management of patients may
Be complicated by the use of other substances, including cannabis, which has been legalized in a number of states. This program updates dental professionals on the current recommendations for the management of opioid overdose, including the indications and contraindications for opioid antagonist administration, and the complications that can arise. Also covered are the pharmacologic characteristics of cannabis and cannabis-derived chemicals, their abuse patterns and the management of dental patients who use cannabis.
Course Objectives:
1. Review the pharmacologic characteristics of opioid antagonists
2. Recognize the signs and symptoms of opioid intoxication
3. Review current recommendations for the dosages and routes of
Administration of opioid antagonists
4. Describe the potential adverse effects of opioid reversal
5. Update knowledge of the action of THC, CBD and other cannabinoids
6. Describe characteristics of cannabis abuse and withdrawal
7. Review the impact of cannabis abuse on oral health and dental care delivery
Course Presenter: Arthur H. Jeske, Ph.D., D.M.D.
Dr. Jeske is Professor, Department of General Practice and Dental Public Health and
Associate Dean for Strategic Planning & Continuing Dental Education, University of Texas School of Dentistry at Houston.He earned his Ph.D. degree (pharmacology) and his D.M.D. degree at the Medical College of Georgia.Dr. Jeske is Editor of Contemporary Dental Pharmacology:Evidence-Based Considerations (Springer Publishing, Berlin), Editor-in-Chief of Mosby’s Dental Drug Reference andSection Editor (Pharmacology) of the Journal of Craniomandibular and Sleep Practice.He has served on the American Dental Association’s Council on Scientific Affairs and served as an Evidence Reviewer for the American Dental Association’s Center for Evidence-Based Dentistry.He is a Fellow of the International College of Dentists, the American College of Dentists, the Academy of Dentistry International and the Pierre Fauchard Academy.Dr. Jeske holds memberships in the ADA, TDA and GHDS, as well as Omicron Kappa Upsilon and Delta Sigma Delta, and he is recipient of the Distinguished Alumnus Award from the Medical College of Georgia School of Dentistry.Dr. Jeske has been in the private practice of general dentistry for 40 years.
'
AGD Subject Code: Chemical Dependency/ Prescribing & Disposal of Prescription Drugs - 134
Cancellation Policy:
Processing and service fees are non-refundable for any and all cancellations with no exceptions. Refunds will only be issued if requested 8 days or more prior to the event. No refunds will be given within 7 days of the event unless the event is canceled by CE Zoom, or unforeseen acts of God, in which we will try and reschedule the event prior to issuing a full refund, minus any processing fees.. Please note, if this is a live-streamed event, you must have a good internet connection and refunds will not be issued due to poor connection or courses not counting for CE credit. If your cancellation/refund request falls within the refund guidelines please email support.cezoom.com and we will be happy to honor your request.
Disclaimer:
The information provided in courses through CE Zoom Partners, LLC (“CE Zoom”) contains content, views, and opinions that may not represent the views of CE Zoom, its associates, and sponsored affiliates. Participants are responsible for verifying the validity, accuracy, and relevance of all content before implementing any techniques, products, or recommendations into their practice. A single continuing education course does not provide enough information to give the participant the necessary expertise on the topic presented.
The content of the courses may not be recorded or copied. The content of the courses is owned by the presenters, CE Zoom, its associates, or sponsored affiliates. Participants may not share or make available, in any way, the content of the courses.
Provider Approval: (ADA-CERP) American Dental Association Continuing Education Recognition Program approved providers, Nationally Recognized (AGD-PACE) Academy of General Dentistry Program approval for Continuing Education
